Aurora Cannabis Files Important Information for Shareholders as AGM Approaches

Aurora Cannabis Inc. Update: Important AGM Filing

Aurora Cannabis Inc. has recently announced that it has completed the filing and mailing of its Management Information Circular in connection with its upcoming Annual General Meeting (AGM) for shareholders. The company, which has made significant strides in the medical cannabis industry, invites its shareholders to actively participate in this important event expected to take place in August 2026.

Preparing for the AGM

Set for Friday, August 7, 2026, at 1:00 p.m. Eastern Time, the AGM will be conducted virtually. This format allows shareholders and proxies to engage fully, no matter their location, securing equitable access for all participants. Shareholders are encouraged to prepare for the meeting by reviewing the details outlined in the Management Information Circular, which is now accessible on the company’s website as well as through SEDAR+.

The deadline for casting votes is set for August 5, 2026, at 1:00 p.m. Eastern Time. Early voting is highly recommended to ensure that every voice is heard. The management team, including CEO Miguel Martin and CFO Simona King, has shared messages that highlight achievements from the fiscal year and what lies ahead for the company, making it essential for all shareholders to vote not just as a duty but as a means to shape the future operations of Aurora.

Empowering Shareholders

The circular shows Aurora's commitment to transparency and management accountability, reinforcing the significance of shareholder participation in the decision-making process. Aurora Cannabis, known for its quality medical cannabis products, urges all shareholders to review the materials thoroughly and ensure the timely submission of their votes. This representation is key, regardless of the number of shares held.

For assistance with the voting process, shareholders can contact Kingsdale Advisors, Aurora's strategic advisor, at 1-800-749-9052 or through their official email. Engaging with the advisory team can facilitate a smooth voting experience and reinforce the importance of shareholder involvement in the AGM.

Aurora’s Role in the Cannabis Industry

As a leader in the medical cannabis space, Aurora Cannabis continues to enhance its global footprint, aligning with its mission of improving patients' lives through quality cannabis offerings. Spanning various countries such as Canada, Australia, Europe, and New Zealand, the company prides itself on its reputable brands like MedReleaf and Pedanios among others. With GMP-certified facilities in Canada and Germany, its commitment to producing reliable and safe medical cannabis products remains resolute.

Moving forward, Aurora aims to leverage its innovations and market position to drive further growth and meet the needs of its diverse customer base. The AGM not only serves as a platform for shareholder dialogue but also marks a crucial juncture for Aurora's future directions and strategic initiatives.

Conclusion

Shareholders of Aurora Cannabis are encouraged to take an active role by voting and engaging in discussions that will shape the future of the company. As the AGM approaches, timely participation will play a critical role in continuing Aurora's trajectory in the global cannabis market. Those interested in learning more about Aurora's position, products, and future plans can visit the company’s website or follow them on social media platforms for the latest updates. As always, your vote is your voice—make it count!